View in EDS

Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis.

Saved in:
Bibliographic Details
Title: Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis.
Authors: Wallwork RS; Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Kotzin JJ; Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, United States., Cappelli LC; Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Mecoli C; Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Bingham CO 3rd; Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Wigley FM; Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Wilson PC; Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, United States., DiRenzo DD; Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, United States., Shah AA; Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: ami.shah@jhmi.edu.
Source: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Aug; Vol. 67, pp. 152460. Date of Electronic Publication: 2024 May 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-866X (Electronic) Linking ISSN: 00490172 NLM ISO Abbreviation: Semin Arthritis Rheum Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-866X
DOI:10.1016/j.semarthrit.2024.152460